We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Treatment of cartilage-hair hypoplasia with recombinant human growth hormone.
- Authors
Obara‐Moszynska, Monika; Wielanowska, Weronika; Rojek, Aleksandra; Wolnik‐Brzozowska, Danuta; Niedziela, Marek
- Abstract
Cartilage-hair hypoplasia ( CHH) is an autosomal recessive disorder characterized by short stature, hypoplastic hair and humoral immunity disorders. It is a mutation in the RMRP gene, located on chromosome 9p13.3, that leads to CHH. There is no special treatment for short stature in CHH. The efficacy and safety of recombinant human growth hormone ( rhGH) therapy in CHH is still under discussion. The present study describes the case of a girl with CHH who was treated with rhGH. The rhGH treatment had a significant effect on the height gain: the height SD score was changed from −4. to −2.98 after 4 years 7 months of treatment. rhGH therapy should be considered as a treatment modality for CHH, and insulin-like growth factor ( IGF)-1 and IGF-binding protein 3 concentrations should be closely monitored, particularly because of the increased cancer risk that is a characteristic feature of CHH.
- Subjects
HUMAN growth hormone; MULTIPLE epiphyseal dysplasia; THERAPEUTICS
- Publication
Pediatrics International, 2013, Vol 55, Issue 6, pe162
- ISSN
1328-8067
- Publication type
Article
- DOI
10.1111/ped.12215